554 related articles for article (PubMed ID: 16547072)
1. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Adachi M; Kurotani R; Morimura K; Shah Y; Sanford M; Madison BB; Gumucio DL; Marin HE; Peters JM; Young HA; Gonzalez FJ
Gut; 2006 Aug; 55(8):1104-13. PubMed ID: 16547072
[TBL] [Abstract][Full Text] [Related]
2. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
3. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
4. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
[TBL] [Abstract][Full Text] [Related]
5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
6. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
[TBL] [Abstract][Full Text] [Related]
7. A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
Da Silva S; Keita ÅV; Mohlin S; Påhlman S; Theodorou V; Påhlman I; Mattson JP; Söderholm JD
Inflamm Bowel Dis; 2018 Mar; 24(4):792-805. PubMed ID: 29529198
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease.
Ahn SH; Shah YM; Inoue J; Morimura K; Kim I; Yim S; Lambert G; Kurotani R; Nagashima K; Gonzalez FJ; Inoue Y
Inflamm Bowel Dis; 2008 Jul; 14(7):908-20. PubMed ID: 18338782
[TBL] [Abstract][Full Text] [Related]
9. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
[TBL] [Abstract][Full Text] [Related]
10. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.
Guri AJ; Mohapatra SK; Horne WT; Hontecillas R; Bassaganya-Riera J
BMC Gastroenterol; 2010 Jun; 10():60. PubMed ID: 20537136
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
[TBL] [Abstract][Full Text] [Related]
13. Role of metallothionein in murine experimental colitis.
Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T
Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591
[TBL] [Abstract][Full Text] [Related]
14. Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis.
Bouguen G; Langlois A; Djouina M; Branche J; Koriche D; Dewaeles E; Mongy A; Auwerx J; Colombel JF; Desreumaux P; Dubuquoy L; Bertin B
Gut; 2015 Jun; 64(6):901-10. PubMed ID: 25053717
[TBL] [Abstract][Full Text] [Related]
15. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis.
Sheng YH; Lourie R; Lindén SK; Jeffery PL; Roche D; Tran TV; Png CW; Waterhouse N; Sutton P; Florin TH; McGuckin MA
Gut; 2011 Dec; 60(12):1661-70. PubMed ID: 21636645
[TBL] [Abstract][Full Text] [Related]
16. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of MMP9 in intestinal epithelium worsens murine acute colitis and is associated with increased levels of proinflammatory cytokine Kc.
Liu H; Patel NR; Walter L; Ingersoll S; Sitaraman SV; Garg P
Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(9):G793-803. PubMed ID: 23471340
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis.
Saubermann LJ; Nakajima A; Wada K; Zhao S; Terauchi Y; Kadowaki T; Aburatani H; Matsuhashi N; Nagai R; Blumberg RS
Inflamm Bowel Dis; 2002 Sep; 8(5):330-9. PubMed ID: 12479648
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis.
Celinski K; Dworzanski T; Fornal R; Korolczuk A; Madro A; Brzozowski T; Slomka M
J Physiol Pharmacol; 2013 Oct; 64(5):587-95. PubMed ID: 24304573
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D Receptor-Dependent Signaling Protects Mice From Dextran Sulfate Sodium-Induced Colitis.
Wang F; Johnson RL; DeSmet ML; Snyder PW; Fairfax KC; Fleet JC
Endocrinology; 2017 Jun; 158(6):1951-1963. PubMed ID: 28368514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
